BIOMEA FUSION INC

BMEA10 Dec 2024
Healthcare
$6.13
-0.05 (-5.08%)
Lowest Today
$5.74
Highest Today
$6.22
Today’s Open
$6.13
Prev. Close
$6.1
52 Week High
$20.21
52 Week Low
$3.61
To Invest in BIOMEA FUSION INC

BIOMEA FUSION INC

Healthcare
BMEA10 Dec 2024
-0.05 (-5.08%)
1M
3M
6M
1Y
5Y
Low
$5.74
Day’s Range
High
$6.22
5.74
52 Week Low
$3.61
52-Week Range
52 Week High
$20.21
3.61
1 Day
-
1 Week
-15.65%
1 month return
-27.8%
3 month return
-23.71%
6 month return
+34.65%
1 Year return
-50.55%
3 Years return
-37.33%
5 Years return
-
10 Years return
-
Institutional Holdings
FMR Inc
14.99
Cormorant Asset Management, LLC
9.85
BlackRock Inc
6.47
Fidelity Growth Compy Commingled Pl S
6.28
Baker Bros Advisors LP
5.82
Fidelity Growth Company Fund
4.49
Vanguard Group Inc
3.86

Market Status

Fundamentals
Market Cap
221.06 mln
PB Ratio
2.91
PE Ratio
0
Enterprise Value
142.67 mln
Total Assets
199.93 mln
Volume

Company Financials

Fund house & investment objective

Company Information
Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, a covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. The company was incorporated in 2017 and is headquartered in Redwood City, California.
Organisation
BIOMEA FUSION INC
Employees
107
Industry
Biotechnology
CEO
Mr. Thomas Andrew Butler
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step